Adiposome Lipidomic Shifts Following Bariatric Surgery in Association With Weight Loss and Cardiometabolic Benefit
The Journal of Clinical Endocrinology & Metabolism · 17.03.2026 · 111 (4) · 964-979
DOI: 10.1210/clinem/dgaf586 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 24.10.2025. Verfasst von Elsayed Metwally und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, College of Medicine, University of Illinois Chicago, Chicago, IL 60612, …. Hauptthemen laut MEDLINE: Bariatric Surgery, Weight Loss, Lipid Metabolism, Obesity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institute of Health.
Abstract (Originalsprache)
Context
Adiposomes carry bioactive lipids that shape systemic metabolism and vascular function.
Objective
Building on our previous findings that obese adiposomes are ceramide/free fatty acid–enriched and linked to dysfunction, we tested whether bariatric surgery remodels adiposome lipidomes and whether these shifts track with metabolic and vascular improvements.
Methods
Twenty-three obese individuals were assessed before and after bariatric surgery. Clinical evaluations included body mass index (BMI), body composition, glycemic markers, inflammatory markers, and vascular function. Adipose tissue biopsies were collected, and adiposomes were isolated for non-targeted lipidomic analysis using mass spectrometry.
Results
Bariatric surgery induced significant reductions in BMI, visceral fat, HOMA-IR, inflammatory markers, and systolic blood pressure, alongside marked improvements in vascular function. Adiposome lipidomics identified 550 species across 19 classes; 124 increased and 66 decreased after surgery. Class-level shifts showed decreases in triglycerides, diglycerides, cholesteryl esters, phosphatidic acids, fatty acids, and acylcarnitines, with increases in phosphocholines, phosphoethanolamines, lysophosphatidylcholines, sphingomyelins, ultralong-chain ceramides, and fatty acid–hydroxy fatty acids (FAHFAs); these changes were larger in participants with ≥20% BMI reduction. Changes in 36 lipid species correlated with BMI change: triglycerides 18:1/20:4/22:6 positively, and sphingomyelins (SM) d40:1, SM d42:4, and phosphatidylcholine 17:0/18:2 inversely. Improvements in nitric oxide, vascular reactivity, and adiponectin tracked with rises in ultralong-chain ceramide/FAHFAs/phospholipids and declines in acylcarnitine/cholesterol esters/diacylglycerols/phosphatidic acids. Machine learning models predicted BMI from lipid features with >80% accuracy (R2 >0.90; mean absolute error <0.3), highlighting SM d40:1, SM d42:4, and fatty acid 17:1 as top contributors. Pathway enrichment analysis linked these changes to sphingolipid signaling and glycerophospholipid metabolism.
Conclusion
Bariatric surgery remodels adiposome lipids, and these shifts align with improvements in cardiometabolic risk markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, College of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.
- Department of Cytology and Histology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt.
- Department of Pharmacology, College of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.
- Department of Surgery, College of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.
- Jesse Brown Veterans Affairs Medical Center, Chicago, IL 60612, USA.
- Department of Kinesiology and Nutrition, College of Applied Health Sciences, University of Illinois Chicago, Chicago, IL 60607, USA.
ORCID-Profile: Brian T Layden, Abeer M Mahmoud
Förderung
- NHLBI NIH HHS
- National Institute of Health
Zitieren
APA
Metwally, E., Burton, L., Mirza, I., Morsy, M. H., Scichilone, G., Mostafa, A., Shimotake, Y., Lighter, M., Bianco, F. M., Hassan, C., Masrur, M. A., Layden, B. T., & Mahmoud, A. M. (2026). Adiposome Lipidomic Shifts Following Bariatric Surgery in Association With Weight Loss and Cardiometabolic Benefit. The Journal of Clinical Endocrinology & Metabolism, 111(4), 964-979. https://doi.org/10.1210/clinem/dgaf586
Vancouver
Metwally E, Burton L, Mirza I, Morsy MH, Scichilone G, Mostafa A, et al. Adiposome Lipidomic Shifts Following Bariatric Surgery in Association With Weight Loss and Cardiometabolic Benefit. The Journal of Clinical Endocrinology & Metabolism. 2026;111(4):964-979. doi:10.1210/clinem/dgaf586
BibTeX
@article{Metwally2026,
author = {Metwally, Elsayed and Burton, Lundon and Mirza, Imaduddin and Morsy, Mohammed H and Scichilone, Giorgia and Mostafa, Amro and Shimotake, Yuko and Lighter, Melani and Bianco, Francesco M and Hassan, Chandra and Masrur, Mario A and Layden, Brian T and Mahmoud, Abeer M},
title = {Adiposome Lipidomic Shifts Following Bariatric Surgery in Association With Weight Loss and Cardiometabolic Benefit},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {4},
pages = {964--979},
doi = {10.1210/clinem/dgaf586}
}
EUVIMED